KTRA Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $19,516.00
Insider Selling (Last 12 Months): $0.00

Kintara Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Kintara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kintara Therapeutics Share Price & Price History

Current Price: $9.43
Price Change: Price Increase of +0.98 (11.60%)
As of 12/7/2022 03:55 PM ET

This chart shows the closing price history over time for KTRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Kintara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2021Anthony Scott PraillCFOBuy28,700$0.68$19,516.00View SEC Filing Icon  
12/6/2021Saiid ZarrabianInsiderBuy11,891$0.59$7,015.69View SEC Filing Icon  
11/22/2021Laura L. JohnsonDirectorBuy3,000$0.74$2,220.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Kintara Therapeutics (NASDAQ:KTRA)

11.07% of Kintara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KTRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Kintara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Vanguard Group Inc.740,814$80K0.0%-47.7%45.842%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC274,300$30K0.0%-62.0%0.339%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC594,813$64K0.0%+411.7%0.736%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC116,234$32K0.0%-82.5%0.177%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC722,400$0.20M0.0%+1,210.7%1.102%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.73,367$0.13M0.0%+182.7%0.150%Search for SEC Filing on Google Icon
5/4/2022swisspartners Ltd.110,000$0.52M0.4%-60.0%0.224%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC54,728$0.12M0.0%+30.9%0.168%Search for SEC Filing on Google Icon
8/16/2021Nantahala Capital Management LLC523,279$1.19M0.0%-42.0%1.604%Search for SEC Filing on Google Icon
8/16/2021State Street Corp107,974$0.25M0.0%+688.1%0.331%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC277,967$0.63M0.0%+82.8%0.852%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,122,231$2.55M0.0%+100.3%3.441%Search for SEC Filing on Google Icon
8/12/2021Golden State Equity Partners71,320$0.16M0.1%N/A0.219%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC76,905$0.13M0.0%N/A0.236%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC41,812$73K0.0%+144.6%0.129%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC76,905$0.13M0.0%N/A0.238%Search for SEC Filing on Google Icon
5/14/2021Nantahala Capital Management LLC902,677$1.57M0.0%+230.7%2.788%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp44,142$77K0.0%+99.8%0.136%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC152,084$0.26M0.0%N/A0.470%Search for SEC Filing on Google Icon
5/12/2021swisspartners Ltd.275,000$0.48M0.4%N/A0.849%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.15,658$27K0.0%N/A0.048%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC40,733$52K0.0%-76.3%0.165%Search for SEC Filing on Google Icon
11/5/2020IPG Investment Advisors LLC26,000$36K0.0%N/A0.105%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC68,359$47K0.0%N/A0.597%Search for SEC Filing on Google Icon
2/10/2020Barclays PLC89,488$62K0.0%N/A0.785%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC66,038$46K0.0%N/A0.579%Search for SEC Filing on Google Icon
1/10/2020FNY Investment Advisers LLC47,000$32K0.0%N/A0.412%Search for SEC Filing on Google Icon
11/27/2019Sabby Management LLC951,454$0.53M0.3%N/A8.346%Search for SEC Filing on Google Icon
4/12/2019Virtu Financial LLC98,554$48K0.0%+99.7%0.385%Search for SEC Filing on Google Icon
11/20/2017Susquehanna International Group LLP364,496$0.31M0.0%N/A1.687%Search for SEC Filing on Google Icon
9/27/2017Sabby Management LLC645,390$1.48M0.1%N/A4.795%Search for SEC Filing on Google Icon
8/15/2017Raymond James Financial Services Advisors Inc.128,580$0.29M0.0%-0.8%0.000%Search for SEC Filing on Google Icon
8/10/2017Franklin Resources Inc.1,076,923$2.48M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Kintara Therapeutics logo
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.
Read More on Kintara Therapeutics

Today's Range

Now: $9.43
Low: $8.75
High: $10.00

50 Day Range

MA: $5.19
Low: $3.65
High: $8.86

52 Week Range

Now: $9.43
Low: $3.50
High: $42.00

Volume

10,453 shs

Average Volume

1,001,522 shs

Market Capitalization

$15.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Kintara Therapeutics?

Kintara Therapeutics' top insider shareholders include:
  1. Anthony Scott Praill (CFO)
  2. Laura L Johnson (Director)
  3. Saiid Zarrabian (Insider)
Learn More about top insider investors at Kintara Therapeutics.

Who are the major institutional investors of Kintara Therapeutics?

Kintara Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 45.84%
  2. Nantahala Capital Management LLC — 0.74%
  3. Renaissance Technologies LLC — 0.34%
Learn More about top institutional investors of Kintara Therapeutics stock.

Which institutional investors are selling Kintara Therapeutics stock?

In the last quarter, KTRA stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Renaissance Technologies LLC

Which institutional investors are buying Kintara Therapeutics stock?

Within the previous quarter, KTRA stock was bought by institutional investors including:
  1. Nantahala Capital Management LLC
In the last year, these company insiders have bought Kintara Therapeutics stock:
  1. Anthony Scott Praill (CFO)
  2. Laura L Johnson (Director)
  3. Saiid Zarrabian (Insider)
Learn More investors buying Kintara Therapeutics stock.